You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Pyxinol ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-062-Tuesday
- By: WANG, Hongbo (Yantai, China)
- Co-author(s): Jinbo Ma: Key lab of Molecular Pharmacology and drug evaluation , Yantai University, Yantai, China
Yanting Yang: Key lab of Molecular Pharmacology and drug evaluation, Yantai University, Yantai, China
Hongbo Wang: Key Lab of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China
Fenghua Fu: Key lab of Molecular Pharmacology and drug evaluation, Yantai University, Yantai, China - Abstract:
Backgrounds
Cisplatin is a chemotherapeutic agent against solid tumors, however, the cisplatin time- and dose-dependent nephrotoxicity is the main adverse effect of cisplatin.Aims
In this study, we investigated whether the pyxinol (DQ) had protective effects against cisplatin-induced nephrotoxicity.Methods
To clarify it, one in vivo model of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026